terbutaline has been researched along with Myocardial Ischemia in 3 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Contrastingly, anoxia selectively increased the AC sensitivity (2-fold) to beta1-adrenergic stimulation." | 1.30 | Enhanced responsiveness of the myocardial beta-adrenoceptor-adenylate cyclase system in the perfused rat heart (I). ( Borchgrevink, PC; Gordeladze, JO; Jynge, I; Sellevold, OF, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seider, N | 1 |
| Abinader, EG | 1 |
| Oliven, A | 1 |
| Martin, RM | 1 |
| Dunn, NR | 1 |
| Freemantle, SN | 1 |
| Mann, RD | 1 |
| Gordeladze, JO | 1 |
| Jynge, I | 1 |
| Borchgrevink, PC | 1 |
| Sellevold, OF | 1 |
1 trial available for terbutaline and Myocardial Ischemia
| Article | Year |
|---|---|
Cardiac arrhythmias after inhaled bronchodilators in patients with COPD and ischemic heart disease.
Topics: Administration, Inhalation; Aged; Arrhythmias, Cardiac; Double-Blind Method; Electrocardiography, Am | 1993 |
2 other studies available for terbutaline and Myocardial Ischemia
| Article | Year |
|---|---|
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.
Topics: Adrenergic beta-Agonists; Adult; Adverse Drug Reaction Reporting Systems; Aged; Albuterol; Anti-Asth | 1998 |
Enhanced responsiveness of the myocardial beta-adrenoceptor-adenylate cyclase system in the perfused rat heart (I).
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Butoxamine; Cell | 1998 |